A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. Health Technol Assess 9:1–160 (2005)

by M Stevenson, Lloyd Jones M, E De Nigris, N Brewer, S Davis, J Oakley